Physician’s Profile

1
Top Doctor: 
1

Jean C. Emond, MD

Department of Surgery
Division of Abdominal Organ Transplant Surgery
Vice Chair, Department of Surgery
Chief of Transplantation
Executive Director, Transplant Initiative, NewYork-Presbyterian/Columbia
Introduction:

Dr. Emond is the Vice Chairman of Surgery and Chief of the Transplantation Services at Columbia University. He has over30 years of experience performing liver transplantation and complex liver and biliary surgery in children and adults, including the first living donor liver transplantation (LDLT) in the United States. Dr. Emond has published extensively in this field and was a co-chair of the NIH A2ALL program for 13 years. In collaboration with the department of Medicine at Columbia, Dr. Emond recruited the leadership of the Columbia Center for Translational immunology that created the foundation for translational and clinical research in transplantation tolerance. This will lead the way to inducing transplant tolerance in liver patients with the mixed chimerism strategy. As Director of Transplantation at the Columbia University Medical Center Dr. Emond’s activities foster clinical excellence and research across all 11 of the solid organ transplant programs at the Medical Center. In recognition of his national and international leadership in transplantation, Dr. Emond is the President-elect of the American Society of Transplant Surgeons, the pre-eminent association of a transplant surgery.

Contribution to Science

Living donor liver transplantation

Dr. Emond has spent a substantial portion of his career developing living donor liver transplantation and studying the safety of the procedure in both the donor and recipient. He participated in the first living donor liver transplant in the United States and focused on refining the techniques of performing living donor liver transplants and split liver transplants. He was also PI of the NIH-sponsored Adult-to-Adult Living Donor Liver Transplantation (A2ALL) consortium to study the safety and outcomes of living donor liver transplants.

Hepatic resection/ischemia

Dr. Emond developed techniques for surgical resection of liver tumors and studied the effect of ischemia during resection on postoperative liver function. These studies include the outcomes of the extent of hepatectomy, the biochemical response to major hepatectomy and ischemia-reperfusion injury of the liver in rodent models. He has studied the clinical safety of inducing total vascular exclusion to provide a bloodless field during the liver transection. This has applications in both liver cancer and living donor hepatectomies.

Hepatocellular carcinoma treatment

Dr. Emond has studied many aspects of managing patients with hepatocellular carcinoma. These studies have included characterizing the risk factors for recurrence of disease following transplantation due to comorbidities and tumor characteristics. The research team has also studied the optimal method of preventing tumor growth in patients with HCC on the liver transplant wait list in addition to optimal strategies of liver allocation to optimize outcomes following liver transplantation. These studies have contributed to proposed changes in UNOS exception point allocation for liver transplant candidates with HCC.

Pediatric liver transplantation

Dr. Emond helped develop the field of pediatric liver transplantation. Contributions to this field include: the use of living donors for pediatric patients; use of auxiliary liver transplants for metabolic diseases; use of partial liver grafts for pediatric patients; and technical modifications that improved outcomes for this patient population.

Areas of Expertise:
  • Transplant Surgery
  • Surgery, General
  • Liver Cancer
  • Cancer Care
  • Pediatric Surgery
  • Biliary Surgery
  • Hepatobiliary Surgery
  • Liver Transplant, Pediatric
  • Transplant Surgery, Pediatric
  • Living Donor Transplantation
  • Liver Resection Surgery
  • Liver Transplantation
Honors & Awards:

Ray and Joan Kroc Travelling Scholarship

Eleanor B. Pillsbury Fellowship

French Government Post-Graduate Scholarship

Fulbright Travel Grant for International Study

Andrew Mellon Young Faculty Member

PEW Scholars Program-University of Chicago nominee

Honorary Faculty Member AOA

Named in The Best Doctors in America Woodward/White, Inc.

Best Doctors in New York (New York Magazine), 2015-2016

Ellis Island Medal of Honor, 2000

Doctor of the Year, Latino Organization for liver awareness, 2000

Publications:

Rudow DL, Brown RS Jr, Emond JC, Marratta D, Bellemare S, Kinkhabwala M. One-year morbidity after donor right hepatectomy.Liver Transpl. 2004 Nov;10(11):1428-31.

Russo MW, Lapointe-Rudow D, Teixeira A, Guarrera J, Dove LD, Gaglio P, Emond JC, Kinkhabwala M, Brown RS. Interpretation of Liver Chemistries in Adult Donors After Living Donor Liver Transplantation. J Clin Gastroenterol. 2004 Oct;38(9):810-4.

Akinlolu O. Ojo, Dennis Heinrichs, Jean C. Emond, Joshua J. McGowan, Mary K. Guidinger, Francis L. Delmonico, Robert A. Metzger. Organ Donation and Utilization in the United States AmJ Transplantation 2004 4(Supp 9):27-37.

Renz JF, Emond JC, Yersiz H, Ascher NL, Busuttil RW. Split liver transplantation in the United States: Outcomes of a national survey. Ann Surg. 2004 Feb;239(2):172-81.

Mark W. Russo, Dianne LaPointe-Rudow, Milan Kinkhabwala, Jean Emond, Robert S. Brown. Impact of adult living donor liver transplantation on waiting time survival in candidates listed for liver transplantation. Am J Transplantation 2004 Mar;4(3):427-31.